HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG ...
Medical Device Network on MSN
HeartBeam commences pilot study of new 12-lead ECG patch
The study will enrol around 50 high-risk coronary artery disease patients whose resting ECGs show no signs of ischemia.
Cleaning materials can also deteriorate the quality of ECG lead wires and result in false alarms on hospital floors, which can increase alarm fatigue among clinical staff. During a May 12 webinar ...
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, ...
HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart ...
Objective: Precordial ECGs reveal significant intrasubject variability due to the inexact employment of the recommended V 1-V 6 chest landmarks. Also, as per the Einthoven law, the six limb leads can ...
Vanessa is a lead writer at CNET, reviewing and writing about the latest smartwatches and fitness trackers. She joined the brand first as an on-camera reporter for CNET's Spanish-language site, then ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
I started with CNET reviewing laptops in 2009. Now I explore wearable tech, VR/AR, tablets, gaming and future/emerging trends in our changing world. Other obsessions include magic, immersive theater, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results